Susan Hoekstra

Statistics

Publications

Citations

H-Index

Active since

1980

Affiliations

Sterling Research Group (United States)(Current)

Susan Hoekstra is an author at Sterling Research Group (United States) specializing in medicine, pharmacology, and receptor tyrosine kinase signaling.

ORCID

Publications per year

1980–2021

Publications

Effects of hypothyroidism on the induction and growth of mammary cancer induced by 7,12-dimethylbenz(a)anthracene in the rat.

Andrew Goodman, Susan Hoekstra, Patricia S. Marsh · PubMed · 1980 · 31 citations

Medicine, Oncology, Pharmacology +12

Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.

Paul E. Juniewicz, Susan Hoekstra, B. M. Lemp et al. · Endocrinology · 1993 · 27 citations

Medicine, Endocrinology, Pharmacology +17

Inhibition of T Lymphocyte Actnation by a Novel p56<sup>lck</sup>Tyrosine Kinase Inhibitor

Connie R. Faltynek, Su Wang, Deborah Miller et al. · Journal of enzyme inhibition · 1995 · 21 citations

Medicine, Medicinal Chemistry, Pharmacology +15

A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC)

Denise A. Yardley, Robyn R. Young, Kerin B. Adelson et al. · Clinical Breast Cancer · 2021 · 11 citations

Medicine, Oncology, Pharmacology +17

1–4 of 4